[HTML][HTML] Brolucizumab shows promise over aflibercept for diabetic macular edema in meta-analysis
L Charters - ophthalmologytimes.com
The current anti-VEGF treatments for DME are associated with a high treatment burden and
poor adherence to the treatment regimen. 2 “Besides socioeconomic constraints, which …
poor adherence to the treatment regimen. 2 “Besides socioeconomic constraints, which …
[HTML][HTML] Comparing brolucizumab and aflibercept for treating DME
L Charters - optometrytimes.com
The current anti-VEGF treatments for DME are associated with a high treatment burden and
poor adherence to the treatment regimen. 2 “Besides socioeconomic constraints, which …
poor adherence to the treatment regimen. 2 “Besides socioeconomic constraints, which …